John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation
John Abraham, Assistant Professor at Christian Medical College and Hospital, shared a post on LinkedIn:
“Recently co-authored a chapter on clotting disorders in pregnancy.
While writing it, I went back and deep dived into the cell-based model of coagulation — and somewhere along the way, something just clicked.
Revisiting the model :
- Initiation gives only a small thrombin signal
- Amplification prepares the platelet surface
- Propagation is where the real action happens – thrombin burst
The system is designed so that effective clotting is platelet-surface driven
The moment of clarity: rFVIIa (NovoSeven)
While going through this, the mechanism suddenly made complete sense:
- If clot formation depends on platelet-surface thrombin generation
- Then you don’t necessarily need the entire intrinsic pathway
rFVIIa at pharmacologic doses:
- Acts directly on activated platelets
- Generates FXa independent of TF
- Bypasses FVIII / FIX
Result: restoration of the thrombin burst exactly where it matters
Why this felt important:
- Explains its efficacy in hemophilia with inhibitors
- Connects physiology – pharmacology in a very direct way
- Turns what feels like a ‘black box drug’ into a predictable mechanism
A good reminder — sometimes revisiting what you already know, but in depth, can change how clearly you see it.”

Stay updated with Hemostasis Today.
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS